XR 808
| Code | Size | Price |
|---|
| TAR-T35188-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
XR 808 is a biochemical.
CAS:
167826-88-2
Formula:
C17H34N2O3
Molecular Weight:
314.47
Purity:
0.98
SMILES:
CCC(CC)C[C@H]1NC(=O)N[C@H](CC(CC)CC)[C@H](O)[C@H]1O
References
Chauchat L, Tanguay C, Caron NJ, Gagn? S, Labr?che F, Bussi?res JF. Surface contamination with ten antineoplastic drugs in 83 Canadian centers. J Oncol Pharm Pract. 2018 Jan 1:1078155218773862. doi: 10.1177/1078155218773862. [Epub ahead of print] PubMed PMID: 29726786.
?kere?ov? M, Mikulov? V, ?apoun O, ?vec D, Kolo?tov? K, Soukup V, Honov? H, Hanu? T, Zima T. Gene Expression Analysis of Immunomagnetically Enriched Circulating Tumor Cell Fraction in Castration-Resistant Prostate Cancer. Mol Diagn Ther. 2018 May 3. doi: 10.1007/s40291-018-0333-0. [Epub ahead of print] PubMed PMID: 29725990.
Pandey G, Mittapelly N, Banala VT, Mishra PR. Multifunctional Glycoconjugate Assisted Nanocrystalline Drug Delivery for Tumor Targeting and Permeabilization of Lysosomal-Mitochondrial Membrane. ACS Appl Mater Interfaces. 2018 May 4. doi: 10.1021/acsami.7b18699. [Epub ahead of print] PubMed PMID: 29726253.
Zhang Y, Lei BH, Zou Q, Zhu QY, Lu ZJ, Wang Y. [Clinical efficacy of integrated traditional Chinese and Western medicine for castration-resistant prostate cancer]. Zhonghua Nan Ke Xue. 2017 Oct;23(10):922-927. Chinese. PubMed PMID: 29727544.